Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SOTALOL AF 80 MG TABLET

SOTALOL HYDROCHLORIDE
$0.0694per EA

Strength

80 mg/1

Manufacturer

Aurobindo Pharma Limited

NDC

59651077501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SOTALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077616

On Market Since

6/29/2023

Pharmacological Classes

Adrenergic beta-Antagonists
Antiarrhythmic
Cardiac Rhythm Alteration

Price History

1W

0.0%

1M

-1.0%

3M

-1.0%

6M

-0.5%

1Y

-7.3%

3Y

N/A

5Y

N/A

All

-16.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

METOPROLOL TARTRATE 25 MG TAB
Generic
00378001801•Mylan Pharmaceuticals Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
00378001805•Mylan Pharmaceuticals Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
51079025520•Mylan Institutional LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817025000•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817025010•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817036000•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817036010•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
57237010001•Rising Pharma Holdings Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
57237010099•Rising Pharma Holdings Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
62332011231•Alembic Pharmaceuticals Inc.
$0.0171
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy